Know Labs' Non-Invasive Glucose Monitoring Technology Shows Improved Accuracy
Portfolio Pulse from Happy Mohamed
Know Labs, Inc. (NYSE:KNW) announced a new study showing improved accuracy of its Bio-RFID sensor technology for non-invasive blood glucose monitoring. The study used a lightGBM machine learning model, achieving a Mean Absolute Relative Difference (MARD) of 12.9%, within the range of FDA-cleared blood glucose monitoring devices.
May 30, 2023 | 1:20 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Know Labs' Bio-RFID sensor technology demonstrates improved accuracy for non-invasive blood glucose monitoring, achieving a MARD of 12.9% using a lightGBM machine learning model.
The improved accuracy of Know Labs' Bio-RFID sensor technology, as demonstrated by the study, is a positive development for the company. Achieving a MARD of 12.9% using a lightGBM machine learning model puts the technology within the range of FDA-cleared blood glucose monitoring devices, which could lead to increased interest and potential adoption of the technology. This is likely to have a positive short-term impact on Know Labs' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100